Location: Palo Alto, CA
CIK: 0001839948 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value: $567M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IVERIC BIO INC | 5,141,118 | $110M | 19.4% | $17.57 | — | COMM | 46583P102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 288,054 | $83.61M | 14.8% | $94.85 | +3.1% | COMM | 558868105 |
| COGT | COGENT BIOSCIENCES INC | 3,631,042 | $41.97M | 7.4% | $8.48 | +46.1% | COMM | 19240Q201 |
| — | CYMABAY THERAPEUTICS INC | 5,905,400 | $37.03M | 6.5% | $3.38 | — | COMM | 23257D103 |
| GERN | GERON CORP | 15,187,073 | $36.75M | 6.5% | $1.36 | +65.3% | COMM | 374163103 |
| SLN | SILENCE THERAPEUTICS PLC | 2,104,875 | $32.1M | 5.7% | $10.03 | — | ADRS | 82686Q101 |
| — | AEROVATE THERAPEUTICS INC | 1,081,274 | $31.68M | 5.6% | $14.29 | — | COMM | 008064107 |
| VRDN | VIRIDIAN THERAPEUTICS, INC | 983,610 | $28.73M | 5.1% | $18.63 | +23.7% | COMM | 92790C104 |
| VTYX | VENTYX BIOSCIENCES, INC | 787,231 | $25.81M | 4.6% | $29.62 | 0.0% | COMM | 92332V107 |
| KALV | KALVISTA PHARMACEUTICALS, INC | 3,395,495 | $22.95M | 4.1% | $5.36 | 0.0% | COMM | 483497103 |
| — | VECTIVBIO HOLDING AG | 2,333,300 | $20.22M | 3.6% | $8.66 | — | COMM | H9060V101 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,144,939 | $18.03M | 3.2% | $15.07 | +6.8% | COMM | 00461U105 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $17.67M | 3.1% | $14.54 | -0.1% | COMM | 50127T109 |
| IMVT | IMMUNOVANT, INC | 854,853 | $15.17M | 2.7% | $12.59 | 0.0% | COMM | 45258J102 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $15.12M | 2.7% | $12.71 | -44.3% | COMM | 90240B106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1,000,000 | $10.5M | 1.9% | $6.29 | +41.5% | COMM | 61559X104 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $7.909M | 1.4% | $17.12 | — | COMM | 29384C108 |
| — | MERUS BV | 300,000 | $4.641M | 0.8% | $30.46 | — | COMM | N5749R100 |
| CABA | CABALETTA BIO, INC | 486,795 | $4.503M | 0.8% | $3.64 | 0.0% | COMM | 12674W109 |
| — | ALPINE IMMUNE SCIENCES INC | 253,069 | $1.86M | 0.3% | $13.85 | — | COMM | 02083G100 |
| — | ELEVATION ONCOLOGY INC | 288,390 | $274K | 0.0% | $6.02 | — | COMM | 28623U101 |